AAAAAA

   
Results: 1-14 |
Results: 14

Authors: WALLER PC
Citation: Pc. Waller, PHARMACOVIGILANCE - TOWARDS THE NEXT MILLENNIUM, British journal of clinical pharmacology, 45(5), 1998, pp. 417-417

Authors: BROWN EG WALLER PC SALLIE BA
Citation: Eg. Brown et al., ADVERSE DRUG-REACTIONS OF THE MONTH - TIAPROFENIC ACID AND SEVERE CYSTITIS, Postgraduate medical journal, 74(873), 1998, pp. 443-444

Authors: EVANS SJW WALLER PC
Citation: Sjw. Evans et Pc. Waller, NEUROLOGICAL, CARDIOVASCULAR AND METABOLIC EFFECTS OF MEFLOQUINE IN HEALTHY-VOLUNTEERS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, British journal of clinical pharmacology, 43(6), 1997, pp. 665-665

Authors: RAWLINS MD BRECKENRIDGE AM WOOD SM WALLER PC COULSON R
Citation: Md. Rawlins et al., ADVERSE DRUG REACTION OF THE MONTH - A NEW SERIES, Postgraduate medical journal, 73(861), 1997, pp. 385-385

Authors: CRAWFORD MLA WALLER PC WOOD SM
Citation: Mla. Crawford et al., SEVERE CYSTITIS ASSOCIATED WITH TIAPROFENIC ACID, British Journal of Urology, 79(4), 1997, pp. 578-584

Authors: WALLER PC WOOD SM LANGMAN MJS BRECKENRIDGE AM RAWLINS MD
Citation: Pc. Waller et al., POSTMARKETING SURVEILLANCE - DEMISE OR REBIRTH, Adverse drug reactions and toxicological reviews, 15(1), 1996, pp. 71-72

Authors: PRICE JS WALLER PC WOOD SM MACKAY AVP
Citation: Js. Price et al., A COMPARISON OF THE POSTMARKETING SAFETY OF 4 SELECTIVE SEROTONIN REUPTAKE INHIBITORS INCLUDING THE INVESTIGATION OF SYMPTOMS OCCURRING ON WITHDRAWAL, British journal of clinical pharmacology, 42(6), 1996, pp. 757-763

Authors: THOMAS SHL BUTT AY CORRIS PA EGAN JJ HIGENBOTTAM TW MADDEN BP WALLER PC
Citation: Shl. Thomas et al., APPETITE-SUPPRESSANTS AND PRIMARY PULMONARY-HYPERTENSION IN THE UNITED-KINGDOM, British Heart Journal, 74(6), 1995, pp. 660-663

Authors: WALLER PC WOOD SM BRECKENRIDGE AM RAWLINS MD
Citation: Pc. Waller et al., WHY THE SAFETY ASSESSMENT OF MARKETED MEDICINES (SAMM) GUIDELINES ARENEEDED, British journal of clinical pharmacology, 38(2), 1994, pp. 93-93

Authors: WALLER PC
Citation: Pc. Waller, GUIDELINES FOR COMPANY-SPONSORED SAFETY ASSESSMENT OF MARKETED MEDICINES (SAMM GUIDELINES), British journal of clinical pharmacology, 38(2), 1994, pp. 95-97

Authors: WALLER PC JACKSON PR TUCKER GT RAMSAY LE
Citation: Pc. Waller et al., CLINICAL-PHARMACOLOGY WITH CONFIDENCE, British journal of clinical pharmacology, 37(4), 1994, pp. 309-310

Authors: WALLER PC
Citation: Pc. Waller, DEALING WITH VARIABILITY - THE ROLE OF PHARMACOVIGILANCE, Journal of Pharmacy and Pharmacology, 46, 1994, pp. 445-449

Authors: WALLER PC
Citation: Pc. Waller, FREQUENCY OF ADVERSE DRUG-REACTIONS - REPLY, British journal of clinical pharmacology, 36(1), 1993, pp. 90-91

Authors: COCKBURN EM WOOD SM WALLER PC BLEEHEN SS
Citation: Em. Cockburn et al., DAPSONE-INDUCED AGRANULOCYTOSIS - SPONTANEOUS REPORTING DATA, British journal of dermatology, 128(6), 1993, pp. 702-703
Risultati: 1-14 |